Dotmatics provides informatics software for the management, query and visualisation of chemistry and biology data. The company’s solutions allow its customers to increase their speed of innovation by improving data quality, enabling users to collaborate across research sites, and reducing time spent on data gathering.

Our investment has enabled Dotmatics to develop its chemistry solutions, further expand into biologics, and make strategic hires in application science, product development and professional services. Systems and processes across all functional areas have been upgraded to ensure that operational scalability meets a growing market opportunity.

By accessing our network, Dotmatics has added international and operational capabilities at board level, introducing a non-executive chairman, a non-executive director, and a chief financial officer. These appointments have brought a depth of experience in scaling life sciences focused software companies, helping the company to refine its international growth strategy and build on its expanding global customer base.

“SEP’s experience of scaling software businesses is boosting our operational and technical capabilities and ensuring we have the depth and breadth of team to take us to the next level internationally.”

Stephen Gallagher, CEO Dotmatics

UK, USA, Japan, South Korea, China
  • 300+


  • 230


  • 5

    global offices

  • 2019

    Queens Award International Trade

Sign up to SEP news